67 Followers on Owler

Vaxart

is a California-based biotechnology company that researches and develops oral recombinant vaccines for the treatment of chronic viral infections and cancer... Read more
OverviewCompetitorsFundingNews & Insights

Vaxart

is a California-based biotechnology company that researches and develops oral recombinant vaccines for the treatment of chronic viral infections and cancer... Read more
Vaxart President & CEO: Steve Lo

President & CEO

Steve Lo

CEO Approval Rating

82/100

2004

PublicNASDAQVXRT

Pharmaceuticals & Biotechnology
Biotechnology
28368731 NAICS listing

Annual Revenue
$255.6M
Employees
120
Funding
$62.9M

News

Conference Presentation
Feb 18, 2026
Marketscreener
Vaxart to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference on February 25, 2026
Partnership
Nov 05, 2025
PR Newswire
Dynavax Enters Exclusive License Agreement for Vaxart's Novel Oral COVID-19 Vaccine Program

Vaxart Competitors

1Emergent
2HilleVax
3Moderna
4Astellas
5Novavax
6Baxter
7FluGen
8Altimmune
9Flexus Biosciences
10Inovio
Unlock 13 + competitors

Trending Companies